Role of identified noncoding RNA in erectile dysfunction

Andrologia. 2020 Aug;52(7):e13596. doi: 10.1111/and.13596. Epub 2020 May 22.

Abstract

Erectile dysfunction (ED) is a common male sexual dysfunction and is closely related to many risk factors such as age, chronic diseases and mental disorder. Phosphodiesterase type 5 inhibitor (PDE5i) is recommended as the first-line medicine in therapy, but up to 35% of patients fail to this treatment. Unfortunately, the pathogenesis of ED is still poorly understood. Hence, it has reached the state that researchers should seek for new candidate biomarkers or therapeutic targets. Recent studies have reported that noncoding RNAs (ncRNAs) such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are involved in the pathogenesis process of ED, even in stem cell therapy. In this review, we aim to summarise the mechanisms and functions of identified ncRNAs that are associated with ED.

Keywords: erectile dysfunction; long noncoding RNA; microRNA; noncoding RNA.

Publication types

  • Review

MeSH terms

  • Erectile Dysfunction* / genetics
  • Humans
  • Male
  • MicroRNAs* / genetics
  • Phosphodiesterase 5 Inhibitors
  • RNA, Long Noncoding* / genetics
  • RNA, Untranslated / genetics

Substances

  • MicroRNAs
  • Phosphodiesterase 5 Inhibitors
  • RNA, Long Noncoding
  • RNA, Untranslated